Delivery Order SPE2DP20D0002-SPE2DP25F5523
Award Date
4/7/25
Potential Completion Date
4/29/25
Potential Value
$991K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $476,414.19 award is for the supply of Adenovirus Type 4, a vaccine, with a completion date of January 30, 2024. This contract is not set aside for any specific business designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries Ltd., a leading global...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, with a ceiling value of $330,313.86, is for the delivery of Adenovirus Type 4 vaccine to support military immunization programs. The contract has an ultimate completion date of April 29, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer. The contract, valued at $990,941.58, is for the delivery of Adenovirus Type 4 vaccine, which is used in military immunization programs. The contract has an ultimate completion date of May 20, 2025. Teva Pharmaceuticals USA, Inc. has established itself as a key supplier to federal healthcare programs,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has a final completion date of September 24, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $330,313.86, is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical pharmaceutical products to federal agencies, including the Department of Veterans Affairs...
This federal contract award, valued at $990,941.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order for the supply of Adenovirus Type 4 vaccine, a critical medical product that supports military immunization programs. The contract is a firm-fixed-price arrangement with a period of performance through March 25, 2025. Teva Pharmaceuticals USA, Inc....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $165,156.93, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a performance period through March 25, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Teva with DLA Troop Support Medical for providing critical pharmaceuticals to support military immunization programs. Teva has also been awarded other significant...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $825,784.65 contract is for the delivery of Adenovirus Type 4 vaccines, which are critical medical products for military immunization programs. Teva is a key supplier to federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD),...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...